Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-02-21 @ 1:51 AM
Study NCT ID:
NCT03520920
Status:
COMPLETED
Last Update Posted:
2024-10-26
First Post:
2018-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)
Sponsor:
BeiGene
Organization: